NEW YORK (GenomeWeb News) – Agilent Technologies has licensed genome partitioning technology from the Broad Institute that will aid in linking genes to diseases, the company said today.
The company plans to use the technology to develop genome-partitioning kits that will incorporate the company’s Oligo Library Synthesis technology.
“We’re working on a simple, highly multiplexed, cost-effective way to enable investigators to remove the sample-preparation bottleneck in sequencing targeted regions of mammalian genomes, using relatively small amounts of input DNA,” said Chad Nusbaum, who is co-director of the Genome Sequencing and Analysis Program at the Broad Institute.
“This work to eliminate the sample-preparation bottleneck of next-generation sequencing will greatly accelerate our understanding of how genes operate,” said Agilent VP and GM of Genomics Yvonne Linney.
Financial terms of the agreement were not released.